Cardinal Health, Inc.

Equities

CAH

US14149Y1082

Pharmaceuticals

Market Closed - Nyse 21:00:02 30/05/2024 BST 5-day change 1st Jan Change
97.71 USD +1.63% Intraday chart for Cardinal Health, Inc. +1.73% -3.07%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Transcript : Cardinal Health, Inc. Presents at 2024 Leerink Partners Healthcare Crossroads Conference, May-29-2024 08:00 AM
Baird Adjusts Price Target on Cardinal Health to $129 From $128 MT
JPMorgan Adjusts Cardinal Health Price Target to $111 From $119 MT
Argus Adjusts Price Target on Cardinal Health to $115 From $120 MT
Transcript : Cardinal Health, Inc. Presents at Bank of America Health Care Conference 2024, May-14-2024 08:00 AM
Cardinal Health Board of Directors Approves Increase to Quarterly Dividend, Payable on July 15, 2024 CI
Deutsche Bank Adjusts Price Target on Cardinal Health to $110 From $116 MT
Jefferies Cuts Cardinal Health's Price Target to $105 From $110 MT
Wells Fargo Raises Cardinal Health's Price Target to $95 From $94 MT
Baird Adjusts Price Target on Cardinal Health to $128 From $134 MT
Leerink Partners Adjusts Cardinal Health Price Target to $120 From $118 MT
Transcript : Cardinal Health, Inc., Q3 2024 Earnings Call, May 02, 2024
Cardinal Health Posts Higher Fiscal Q3 Non-GAAP Earnings, Revenue; Raises Fiscal 2024 Earnings Guidance MT
Earnings Flash (CAH) CARDINAL HEALTH Reports Q3 Revenue $54.91B, vs. Street Est of $56.11B MT
Earnings Flash (CAH) CARDINAL HEALTH Posts Q3 EPS $2.08, vs. Street Est of $1.95 MT
Cardinal Health, Inc. Provides Preliminary Earnings Guidance for Fiscal Year 2025 CI
Cardinal Health, Inc. Raises Its Earnings Guidance for Fiscal Year 2024 CI
Cardinal Health, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 CI
Cardinal Health, Inc. Reports Impairment Charges for the Third Quarter Ended March 31, 2024 CI
Futures climb as Fed allays rate-hike worries RE
Wells Fargo Adjusts Cardinal Health Price Target to $94 From $96 MT
US FDA sends warning to Cardinal Health for marketing unapproved devices RE
Evercore ISI Adjusts Cardinal Health's Price Target to $110 From $118, Keeps In Line Rating MT
Morgan Stanley Adjusts Cardinal Health's Price Target to $114 From $117, Maintains Overweight Rating MT
Sector Update: Health Care Stocks Increase Late Afternoon MT
Chart Cardinal Health, Inc.
More charts
Cardinal Health, Inc. is specialized in the distribution of products and health services to pharmacies, hospitals and medical practices. Net sales break down by activity as follows: - distribution of pharmaceutical products (92.7%); - distribution of medical, surgical and laboratory products (7.3%). The group also develops a manufacturing of medical and surgical products activity (masks, overalls, gloves, diagnostic products, products of aspiration and collection of liquids, radiology intervention, respiratory assistance, etc.). The United States accounts for 97.7% of net sales.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
16
Last Close Price
97.72 USD
Average target price
111.9 USD
Spread / Average Target
+14.47%
Consensus
  1. Stock Market
  2. Equities
  3. CAH Stock
  4. News Cardinal Health, Inc.
  5. Baird Adjusts Cardinal Health's Price Target to $73 From $57, Maintains Neutral Rating